Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




More Accurate Test Gives Indication of Early Meningococcal Infection

By LabMedica International staff writers
Posted on 05 Nov 2013
A more accurate method to screen for bacterial meningitis, when it is in its earliest stage, has been proposed.

Researchers from the University of Missouri School of Medicine (Kansas City, MO, USA) have found a more accurate method to screen for bacterial meningococcal infection in its early stages, when it's hardest to detect. More...
According to the researchers, the method for diagnosis could save lives by getting patients treatment earlier, when the infection is most treatable.

Michael Cooperstock, MD, professor of child health in the Division of Pediatric Infectious Diseases at the MU School of Medicine, medical director of infection control at University of Missouri Health Care and senior author of the study said, "When we talk about early diagnosis, we're not talking about days, but rather hours and even minutes."

"Diagnosis of most bacterial infections traditionally has relied upon the detection of an increase in the total number of white blood cells," said Prof. Cooperstock. "That's because an increase in a patient's white blood cell count is an indication of acute inflammation associated with infection."

When the investigators studied 216 cases from the US Multicenter Meningococcal Surveillance Study, they found that 33% of the patients with active infections had total white blood cell counts that appeared normal. After examining the patients' blood tests more closely, the researchers found that a better indicator of infection was not the total white blood cell count but rather abnormalities in two particular types of white blood cells called neutrophils.

"When we looked at the neutrophil counts of each patient, we examined not only the total number of neutrophils, but also the number of immature neutrophils and the ratio of immature to total neutrophil cells," Prof. Cooperstock said. "We found that 94% of the patients showed an abnormality of one or more of these three tests, indicating a serious infection might be present. Reliance on the total white blood cell count alone, however, would have given false reassurance that infection was not present in more than 30% of those cases."

The researchers concluded that if any of the three neutrophil indicators are outside a certain range, there is a possibility that the patient has a serious bacterial infection, including the possibility of meningococcal disease, and would need careful attention.

The study was published in the October 2013 edition of the Pediatric Infectious Disease Journal.

Related Links:

University of Missouri School of Medicine



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.